MBTPS2 and osteogenesis imperfecta: These data suggest that the activity of SREBP in activating transcription of its target genes is impaired in cells carrying pathogenic variants of MBTPS2, with a stronger impairment seen in cells with OI variants than in cells with IFAP/KFSD variants.